About Isis Pharmaceuticals

[steroidjuicebar]

Isis Pharmaceuticals, now known as Ionis Pharmaceuticals, is a biopharmaceutical company that specializes in the development of antisense therapeutics. Antisense therapeutics are a type of drug that work by binding to specific sequences of RNA in order to disrupt the production of disease-causing proteins. This approach is different from traditional drugs, which typically work by binding to specific proteins.

Isis Pharmaceuticals was founded in 1989 by Dr. Stanley Crooke and has since become a leader in the field of antisense therapeutics. The company has a broad pipeline of drugs in development for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.

One of Isis Pharmaceuticals' most notable achievements is the development of Kynamro (mipomersen), a drug that is used to treat homozygous familial hypercholesterolemia (HoFH), a rare genetic disorder that causes very high levels of LDL cholesterol. Kynamro was approved by the US Food and Drug Administration (FDA) in 2013 and is the first antisense drug to be approved for use in humans.

Isis Pharmaceuticals also has several drugs in late-stage clinical development, including volanesorsen, a drug for the treatment of familial chylomicronemia syndrome (FCS) and hypertriglyceridemia, and nusinersen, a drug for the treatment of spinal muscular atrophy (SMA). Nusinersen was approved by the FDA in 2016 and is the first and only treatment for SMA.

In addition to its drug development efforts, Isis Pharmaceuticals has also established partnerships with several large pharmaceutical companies, including GlaxoSmithKline, AstraZeneca, and Biogen. These partnerships have allowed the company to leverage the resources and expertise of these larger companies to further advance its drug development programs.

In December 2015, the company changed its name to Ionis Pharmaceuticals, to reflect its focus on developing drugs that target the genetic causes of diseases.

Overall, Isis Pharmaceuticals (Ionis Pharmaceuticals) is a leading biopharmaceutical company in the field of antisense therapeutics. Its pipeline of drugs in development for a variety of diseases and its partnerships with large pharmaceutical companies position the company well for continued success in the future.

One of the best sources for the Isis's product is “Steroid Juice Bar”.